Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | TPMT | P51580 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28448881 | 0.97 | ALDH1A1 (0.36) | ALDH1A1TSHRACHE | |
| Dimethylamine SCHEMBL8628126 | 0.92 | ALDH1A1 (0.33) | ALDH1A1TSHRHTTNPSR1 | |
| SCHEMBL2229083 | 0.79 | ALDH1A1 (0.40) | ALDH1A1TSHRACHETPMT | |
| SCHEMBL4453304 | 0.79 | ALDH1A1 (0.40) | ALDH1A1TSHRACHETPMT | |
| SCHEMBL21409639 | 0.78 | ALDH1A1 (0.35) | ALDH1A1TSHRNOS3NOS2 | |
| SCHEMBL27932150 | 0.77 | ALDH1A1 (0.38) | ALDH1A1TSHRACHETPMTHTT | |
| Hydrochloric Acid SCHEMBL29193780 | 0.76 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL8331798 | 0.74 | ACHE (0.44) | ALDH1A1TSHRACHEHTTNPSR1 | |
| SCHEMBL2228016 | 0.74 | ALDH1A1 (0.36) | ALDH1A1TSHRACHETPMT | |
| SCHEMBL2282469 | 0.74 | ALDH1A1 (0.36) | ALDH1A1TSHRACHETPMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2723701-A1 | PROCESSES FOR PREPARING PHOSPHORUS-CONTAINING ALPHA- AND BETA-AMINO ACIDS AND DERIVATIVES THEREOF | Diverchim (FR) | 2014-04-30 | — | — | EP | claimed |
| WO-2012175837-A1 | PROCESSES FOR PREPARING PHOSPHORUS-CONTAINING Α- AND Β-AMINO ACIDS AND DERIVATIVES THEREOF | DIVERCHIM (FR) | 2012-12-27 | — | — | WO | claimed |
| CN-120157599-A | Compounds for light absorbers | 株式会社LMS | 2025-06-17 | — | — | CN | disclosed |
| CN-107690436-B | Method for forming complexes, complexes and use thereof | 庄信万丰股份有限公司 | 2023-12-22 | — | — | CN | disclosed |
| US-20230381764-A1 | USE OF HIGHLY ISOSELECTIVE, THERMALLY STABLE FERROCENE CATALYSTS FOR PROPYLENE HYDROFORMYLATION | EASTMAN CHEMICAL COMPANY (US) | 2023-11-30 | — | — | US | disclosed |
| US-20230382937-A1 | PROCESSES OF PREPARING FERROCENE LIGAND MIXTURES SUITABLE FOR PROPYLENE HYDROFORMYLATION | EASTMAN CHEMICAL COMPANY (US) | 2023-11-30 | — | — | US | disclosed |
| EP-3360880-B1 | PROCESS FOR THE PREPARATION OF CIS-RUTHENIUM OR -OSMIUM COMPLEXES | JOHNSON MATTHEY PLC (GB) | 2022-04-13 | — | — | EP | disclosed |
| CN-110551036-B | Iridium/chiral phosphite ester-pyridine catalyzed imine asymmetric hydrogenation method | 中国科学院大连化学物理研究所 | 2022-04-12 | — | — | CN | disclosed |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | SYNGENTA PARTICIPATIONS AG (CH) | 2021-07-06 | — | — | US | disclosed |
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2020-12-31 | — | — | US | disclosed |
| EP-2774908-B1 | METHOD FOR PREVENTING DECREASE IN OPTICAL PURITY | TAKASAGO PERFUMERY CO LTD (JP) | 2017-02-08 | — | — | EP | disclosed |
| EP-2774908-A1 | METHOD FOR PREVENTING DECREASE IN OPTICAL PURITY | Takasago International Corporation (JP) | 2014-09-10 | — | — | EP | disclosed |
| EP-2695887-A1 | NOVEL RUTHENIUM COMPLEX AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND USING SAME AS CATALYST | Takasago International Corporation (JP) | 2014-02-12 | — | — | EP | disclosed |
| EP-2007703-A1 | METAL COMPLEXES FOR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | Lucite International UK Limited (GB) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007119079-A1 | METAL COMPLEXES FOR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2007-10-25 | — | — | WO | disclosed |
| EP-0848697-A1 | PROCESS FOR THE HYDROGENATION OF IMINES | Novartis AG (CH) | 1998-06-24 | — | — | EP | disclosed |
| WO-1997005095-A1 | PROCESS FOR THE HYDROGENATION OF IMINES | NOVARTIS AG (CH) | 1997-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230381764-A1 | USE OF HIGHLY ISOSELECTIVE, THERMALLY STABLE FERROCENE CATALYSTS FOR PROPYLENE HYDROFORMYLATION | FTH1, HMOX1, PORCN | ALDH1A1 355/4885TSHR 4696/4885ACHE 4389/4885 |
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | TBCB, ADORA2B, ADRA2B | ALDH1A1 955/4885TSHR 3362/4885ACHE 1382/4885 |
| US-20230382937-A1 | PROCESSES OF PREPARING FERROCENE LIGAND MIXTURES SUITABLE FOR PROPYLENE HYDROFORMYLATION | FTH1, FOLR1, FECH | ALDH1A1 1889/4885TSHR 1624/4885ACHE 4634/4885 |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | TBCB, ADORA2B, CCNB3 | ALDH1A1 979/4885TSHR 3327/4885ACHE 1403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.